Market Research Report Insights

The global  tissue engineered skin substitutes market  size is expected to reach USD 947.3 million by 2027, expanding at a CAGR of 4.7%, according to a new report by Grand View Research, Inc. Technological advancements, high demand for skin grafts, and rising prevalence of acute wounds are the key driving factors for the market. Rising demand for skin grafts is a major factor boosting market growth. The recent trend of burn care and treatment has shifted to a more comprehensive approach which not only focuses on recovery from burn injury but also on improvement in long-term function and form of the healed injury and quality of life. Owing to this trend the demand for use of grafting and other substitutes in treatment and management of acute burns has increased and is rising at a constant pace. Skin grafts are majorly used on partial and full thickness burns and have an important role in treatment of burn injuries. The grafts can be biological or synthetic in nature. Biol...

The global healthcare contract development and manufacturing organization market size is expected to reach USD 352.3 billion by 2027, registering a CAGR of 8.1% over the forecast period, according to a new report by Grand View Research, Inc. Increasing outsourcing of R&D is one of the major factors contributing to the market growth. Healthcare contract development and manufacturing organization (CDMO) provides outsourcing services to various pharmaceutical industries on contract basis. Increase in the outsourcing by pharmaceutical companies, growing pharmaceutical industry, and support of CDMOs in reducing the operational and capital expenses are some of the major factors anticipated to propel the market growth over the forecast period. In addition, growing pressure on pharmaceutical and medical device companies to follow stringent timelines has increased the demand for outsourcing development and manufacturing activities to CDMOs. Further, due to increasing demand for medic...

The global lancets market size is expected to reach USD 5.1 Billion by 2027, registering a CAGR of 5.6% over the forecast period, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing incidence of infectious diseases, coupled with advancement in the field of diagnostic testing. Furthermore, increasing awareness about self-monitoring of blood glucose, coupled with improved accuracy in self diagnostic among patients, is adding to the market growth. Rapidly changing lifestyle such as unhealthy food, consumption of alcohol, and lack of physical activities is increasing the incidence of lifestyle associated chronic diseases. Rising government expenditure and technological advancement in the field of diabetes management are expected to drive the market. Furthermore, increasing preference for home care settings and growing trend of using advanced lancet devices, including automatic versions, are some of the factors expected to drive the marke...

The global drug delivery devices market size is expected to reach USD 345.8 billion by 2027, expanding at a CAGR of 6.15% over the forecast period, according to a new report by Grand View Research, Inc. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market. Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehic...

The global COVID-19 drug delivery devices market is anticipated to be worth USD 2.15 billion by the year 2027, advancing at a healthy CAGR of 8.1% during this period, according to a recent GVR report. The spread of the COVID-19 pandemic across the world since the beginning of 2020 has been swift, with countries, both developed and developing, reeling from its impact. With more than 15 million confirmed cases and more than 610,000 deaths globally, the pandemic is expected to sustain its impact over the coming months. The outbreak has seen an unprecedented surge in research and development of various drugs and vaccines, with many established organizations entering into partnerships to develop an effective combatant to coronavirus. The drug development phase began almost as soon as the pandemic started its global spread from China; however, there are still vast improvements to be made in this regards, with many of them still in the trial phase, which would ensure the growth of the ma...

The global healthcare staffing market size is likely to reach USD 48.6 billion by 2027 at a CAGR of 5.4% over the forecast period, based on a new report by Grand View Research, Inc. The rising demand for temporary nursing staff especially due to growing geriatric population is boosting the scope for these services across the world. In 2010, the Association of American Medical Colleges estimated that U.S. might face a shortfall of 150,000 doctors during the next 10-15 years. In August 2019, the National Association of Locum Tenens Organizations (NALTO) stated that 90% of the U.S. healthcare facilities use locum tenens providers and over 50,000 physicians work on locum tenens projects every year. The increasing number of physicians choosing to work as locum tenens is expected to propel the market growth over the forecast period. Furthermore, the hospitals are forced to reduce the staff and implement policies for ensuring the availability of nurses upon an increase in the workload,...